Indulgence

Voxtur Pharma on OVIS platform - Expanding OVIS coverage in South India



September 10th 2018

OVIS - the Indian national Cross Participation Platform for to obtain Clean Volunteers for BA BE studies has expanded its network in South India.

Voxtur Clinical Research Pvt Ltd. has joined the OVIS platform. Voxtur shall be operating its studies from Chennai, Tamilnadu.

OVIS offer Clean Volunteers for Risk Free studies based on the blood regeneration and drug washout parameters. The India wide Volunteers Eligibility Platform

OVIS has traced 1.3+ million In-eligible volunteers and has avoided Drug Reaction issues in them. Further OVIS has approved 2.5+ million volunteers for various studies across the country.

 

#OVIS #ClinicalResearch #CRO #LifeScience #ClinicalStudy #HumanVolunteers #CleanVolunteers #RiskFreeStudies #CrossParticipation #PhaseI #PhaseIII #EarlyStage #DrugTesting #ScreeningEligibility #DosingEligibility #RiskMitigation #HealthyVolunteers #LowCostStudies #SafeStudies #ADR #SADR #AvoidADR #DrugConcentration #RealTimeStatus #USFDA #CFR11 #BA #BE #PKStudies